Pulmonx to Report Q1 2026 Earnings on April 29

Medical device company Pulmonx will announce its first quarter 2026 financial results next month.

Apr. 15, 2026 at 8:05pm

Got story updates? Submit your updates here. ›

An extreme close-up of highly detailed, metallic medical devices and machinery, conveying the advanced, industrial nature of Pulmonx's minimally invasive lung treatments.Pulmonx's innovative medical devices and diagnostic tools represent the cutting edge of minimally invasive lung disease treatments.Redwood City Today

Pulmonx Corporation, a global leader in minimally invasive treatments for lung disease, announced that it will release its financial results for the first quarter of 2026 after the market close on Wednesday, April 29, 2026. The company will host a conference call to discuss the results starting at 1:30 p.m. PT / 4:30 p.m. ET.

Why it matters

As a publicly traded medical device company, Pulmonx's quarterly earnings reports provide important updates on the commercial performance and financial health of its innovative lung disease treatments, including the Zephyr Endobronchial Valve which is considered a standard of care option for patients with severe emphysema.

The details

Pulmonx will report Q1 2026 results after the market close on April 29, 2026. The company will then host a conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results. A live and archived webcast of the call will be available on Pulmonx's investor relations website.

  • Pulmonx will report Q1 2026 results on April 29, 2026.
  • The company will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET on April 29, 2026.

The players

Pulmonx Corporation

A global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD), including the Zephyr Endobronchial Valve which is commercially available in over 25 countries.

Brian Johnston

A representative from the Gilmartin Group, which handles investor relations for Pulmonx.

Got photos? Submit your photos here. ›

What they’re saying

“A live and archived webcast of the event will be available on the 'Investors' section of the Pulmonx website at https://investors.pulmonx.com/.”

— Pulmonx Corporation

What’s next

Investors and analysts will be able to access the Q1 2026 earnings call and webcast on Pulmonx's investor relations website to get the latest updates on the company's financial performance and business outlook.

The takeaway

As a leading provider of minimally invasive treatments for lung disease, Pulmonx's quarterly earnings reports are closely watched by the medical technology industry and investors. The upcoming Q1 2026 results will shed light on the continued commercial adoption and financial health of the company's innovative respiratory products.